Journal Article Summary
The article investigates the relationship between the use of antihistamines by allergic women before or during pregnancy and the risk of developing early-onset pre-eclampsia. This topic is significant because early-onset pre-eclampsia is a serious condition that can lead to severe complications for both the mother and the baby. Understanding whether antihistamines can influence this risk could help in managing pregnancies for women with allergies, who are already at a higher risk for this condition.
The study analyzed data from nearly 700,000 pregnancies in Norway between 2004 and 2016, focusing on women who were prescribed antihistamines. The researchers categorized the timing of antihistamine use into three groups: before pregnancy, early pregnancy, and late pregnancy. They found that women who used antihistamines before or during early pregnancy had a lower risk of developing early-onset pre-eclampsia compared to those who only used them in late pregnancy. This suggests that the timing of antihistamine use is crucial, as it may help mitigate the risk associated with pre-existing allergies.
However, the study has limitations, including the reliance on prescription data to identify allergic women, which may not capture all cases of allergy. Additionally, the study did not account for over-the-counter antihistamine use, which could affect the results. Patients should discuss their antihistamine use and any concerns about pre-eclampsia with their healthcare provider, especially if they have allergies, to ensure they receive appropriate guidance tailored to their individual health needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Sande Anne K, Torkildsen Erik Andreas, Sande Ragnar Kvie, Dalen Ingvild, Danielsson Kim Christian, Morken Nils-Halvdan. Use of antihistamines before or during pregnancy and risk of early-onset pre-eclampsia in allergic women: a population-based cohort study. BMJ Open 2022. DOI: 10.1136/bmjopen-2022-061837. PMID: 36207047. PMCID: PMC9557799.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
